Header Logo

Connection

ANNA MALOVANNAYA to Animals

Back to Details
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Animals.
ANNA MALOVANNAYA
Connection Strength
0.335
Animals
  1. gpGrouper: A Peptide Grouping Algorithm for Gene-Centric Inference and Quantitation of Bottom-Up Proteomics Data. Mol Cell Proteomics. 2018 11; 17(11):2270-2283.
    View in: PubMed
    Score: 0.035
  2. Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 Feb 06; 145(6):612-624.
    View in: PubMed
    Score: 0.014
  3. Sex Differences in Response to Diet Enriched With Glutathione Precursors in the Aging Heart. J Gerontol A Biol Sci Med Sci. 2025 Jan 16; 80(2).
    View in: PubMed
    Score: 0.014
  4. Large-scale CRISPR/Cas9 deletions within the WFDC gene cluster uncover gene functionality and critical roles in mammalian reproduction. Proc Natl Acad Sci U S A. 2024 Dec 17; 121(51):e2413195121.
    View in: PubMed
    Score: 0.014
  5. PKC-mediated phosphorylation governs the stability and function of CELF1 as a driver of EMT in breast epithelial cells. J Biol Chem. 2024 Nov; 300(11):107826.
    View in: PubMed
    Score: 0.014
  6. BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood. 2024 05 16; 143(20):2059-2072.
    View in: PubMed
    Score: 0.013
  7. Atrial proteomic profiling reveals a switch towards profibrotic gene expression program in CREM-Ib?C-X mice with persistent atrial fibrillation. J Mol Cell Cardiol. 2024 May; 190:1-12.
    View in: PubMed
    Score: 0.013
  8. Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
    View in: PubMed
    Score: 0.013
  9. CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames. Nat Struct Mol Biol. 2023 Dec; 30(12):1878-1892.
    View in: PubMed
    Score: 0.013
  10. Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023 10 02; 83(19):3237-3251.
    View in: PubMed
    Score: 0.013
  11. Molecular dissection and testing of PRSS37 function through LC-MS/MS and the generation of a PRSS37 humanized mouse model. Sci Rep. 2023 07 14; 13(1):11374.
    View in: PubMed
    Score: 0.012
  12. Magel2 truncation alters select behavioral and physiological outcomes in a rat model of Schaaf-Yang syndrome. Dis Model Mech. 2023 02 01; 16(2).
    View in: PubMed
    Score: 0.012
  13. Testis-specific serine kinase 3 is required for sperm morphogenesis and male fertility. Andrology. 2023 07; 11(5):826-839.
    View in: PubMed
    Score: 0.012
  14. Sex-specific phenotypes in the aging mouse heart and consequences for chronic fibrosis. Am J Physiol Heart Circ Physiol. 2022 08 01; 323(2):H285-H300.
    View in: PubMed
    Score: 0.012
  15. Intestinal Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell Compartment. Arterioscler Thromb Vasc Biol. 2022 04; 42(4):381-394.
    View in: PubMed
    Score: 0.011
  16. Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy. Nat Commun. 2022 01 10; 13(1):134.
    View in: PubMed
    Score: 0.011
  17. Multiplexed drug-based selection and counterselection genetic manipulations in Drosophila. Cell Rep. 2021 09 14; 36(11):109700.
    View in: PubMed
    Score: 0.011
  18. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.
    View in: PubMed
    Score: 0.010
  19. Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation. Elife. 2020 04 22; 9.
    View in: PubMed
    Score: 0.010
  20. MiR-146a wild-type 3' sequence identity is dispensable for proper innate immune function in vivo. Life Sci Alliance. 2019 02; 2(1).
    View in: PubMed
    Score: 0.009
  21. DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer. Proc Natl Acad Sci U S A. 2018 12 18; 115(51):E11978-E11987.
    View in: PubMed
    Score: 0.009
  22. FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res. 2018 08 01; 78(15):4229-4240.
    View in: PubMed
    Score: 0.009
  23. Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 03 28; 8:14864.
    View in: PubMed
    Score: 0.008
  24. An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways. Mol Cell Proteomics. 2017 04; 16(4):581-593.
    View in: PubMed
    Score: 0.008
  25. The Dual Estrogen Receptor a Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety. Mol Pharmacol. 2016 Jan; 89(1):14-26.
    View in: PubMed
    Score: 0.007
  26. SRC-2 orchestrates polygenic inputs for fine-tuning glucose homeostasis. Proc Natl Acad Sci U S A. 2015 Nov 03; 112(44):E6068-77.
    View in: PubMed
    Score: 0.007
  27. In-depth proteomic characterization of endogenous nuclear receptors in mouse liver. Mol Cell Proteomics. 2013 Feb; 12(2):473-84.
    View in: PubMed
    Score: 0.006
  28. Minireview: nuclear receptor and coregulator proteomics--2012 and beyond. Mol Endocrinol. 2012 Oct; 26(10):1646-50.
    View in: PubMed
    Score: 0.006
  29. Recovering protein-protein and domain-domain interactions from aggregation of IP-MS proteomics of coregulator complexes. PLoS Comput Biol. 2011 Dec; 7(12):e1002319.
    View in: PubMed
    Score: 0.006
  30. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell. 2006 Jan 27; 124(2):381-92.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.